20 results on '"Gracheva, Nadezda"'
Search Results
2. Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617
3. Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy
4. Sorption and speciation of iodine in boreal forest soil
5. First-in-Humans Application of 161Tb: A Feasibility Study Using 161Tb-DOTATOC
6. Development of Terbium and Erbium Radiolanthanides for Radiopharmaceutical Application
7. First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC.
8. 165Er: A new candidate for Auger electron therapy and its possible cyclotron production from natural holmium targets
9. Determination of 161Tb half-life by three measurement methods
10. Additional file 1: of Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy
11. Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617.
12. Sorption and speciation of iodine in boreal forest soil
13. Am(III) sorption onto TiO2 samples with different crystallinity and varying pore size distributions
14. Am(III) sorption onto TiO2 samples with different crystallinity and varying pore size distributions.
15. Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy.
16. Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy
17. Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
18. First-in-Humans Application of 161 Tb: A Feasibility Study Using 161 Tb-DOTATOC.
19. Determination of 161 Tb half-life by three measurement methods.
20. 165 Er: A new candidate for Auger electron therapy and its possible cyclotron production from natural holmium targets.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.